Prevenotics-G Pro is revolutionizing the prevention of gastric cancer through its groundbreaking AI platform. This system delivers real-time endoscopic diagnostics for conditions ranging from pre-cancerous to malignant, utilizing an advanced multi-modal AI surveillance system designed to optimize preventive care.

With global survival rates for gastric cancer alarmingly low at 20-40%, our mission to achieve "cancer zero" is both urgent and critical. Through systematic preventive management, our platform facilitates early intervention at the pre-cancerous stage, where the potential impact is most substantial.
Our innovative technology, protected by existing and pending patents, is currently undergoing clinical validation in leading medical institutions. Its continued advancement is driven by close collaboration with globally recognized experts in gastric cancer prevention.

With Prevenotics-G Pro, we are not merely developing technology; we are aiming to transform survival outcomes in the management of gastric cancer.